RE:RE:HERE IS THE newsThis seems to be a pretty definitive comment,
"Nextleaf expects to announce a future R&D and innovation agreement with a large strategic partner operating in the cannabis or pharmaceutical space."
Certainly feel the debenture purchase may be related to this future strategic investment. The investor merely wanted their foot in the door with just under a 10% of the share float. The fact the investment was dated March 31st (end of quarter) may be another facture as too keeping this quiet for at least three months, from that date.